Tissue Repair Ltd is a clinical stage biopharmaceutical company developing an advanced wound healing technology targeting applications in the chronic wound and cosmetic procedure markets. Tissue Repair has developed a unique active ingredient that is designed for wound healing and delivered topically. The biologically active pharmaceutical ingredient behaves like a decoy cell and simulates a yeast infection resulting in the stimulation of the body’s own wound repair pathways. This active ingredient also provides a platform for the opportunity to develop a range of products that have the potential to treat a broad range of conditions across the wound care market.